Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study
- 1 April 2019
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 44, 113-119
Abstract
No abstract availableKeywords
Funding Information
- GSK
- Novartis
This publication has 19 references indexed in Scilit:
- Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IXJournal of Clinical Oncology, 2013
- Triple-negative breast cancer: epidemiological considerations and recommendationsAnnals of Oncology, 2012
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer SubtypesJournal of Clinical Oncology, 2012
- Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving TherapyJournal of Clinical Oncology, 2011
- Breast Cancer Subtypes and the Risk of Local and Regional RelapseJournal of Clinical Oncology, 2010
- Clinical Characteristics and Outcome of Treatment of Brazilian Women with Breast Cancer Treated at Public and Private Institutions – The AMAZONE Project of the Brazilian Breast Cancer Study Group (GBECAM).Cancer Research, 2009
- Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker PanelJournal of Clinical Oncology, 2009
- Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of SwitzerlandAnnals of Oncology, 2008
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Quality of Breast Cancer Care: What Do We Know?Journal of Clinical Oncology, 2002